Elevated post-ischemic ubiquitination results from suppression of deubiquitinase activity and not proteasome inhibition
- 5 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 78 (5), 2169-2183
- https://doi.org/10.1007/s00018-020-03625-5
Abstract
Cerebral ischemia–reperfusion increases intraneuronal levels of ubiquitinated proteins, but the factors driving ubiquitination and whether it results from altered proteostasis remain unclear. To address these questions, we used in vivo and in vitro models of cerebral ischemia–reperfusion, in which hippocampal slices were transiently deprived of oxygen and glucose to simulate ischemia followed by reperfusion, or the middle cerebral artery was temporarily occluded in mice. We found that post-ischemic ubiquitination results from two key steps: restoration of ATP at reperfusion, which allows initiation of protein ubiquitination, and free radical production, which, in the presence of sufficient ATP, increases ubiquitination above pre-ischemic levels. Surprisingly, free radicals did not augment ubiquitination through inhibition of the proteasome as previously believed. Although reduced proteasomal activity was detected after ischemia, this was neither caused by free radicals nor sufficient in magnitude to induce appreciable accumulation of proteasomal target proteins or ubiquitin–proteasome reporters. Instead, we found that ischemia-derived free radicals inhibit deubiquitinases, a class of proteases that cleaves ubiquitin chains from proteins, which was sufficient to elevate ubiquitination after ischemia. Our data provide evidence that free radical-dependent deubiquitinase inactivation rather than proteasomal inhibition drives ubiquitination following ischemia–reperfusion, and as such call for a reevaluation of the mechanisms of post-ischemic ubiquitination, previously attributed to altered proteostasis. Since deubiquitinase inhibition is considered an endogenous neuroprotective mechanism to shield proteins from oxidative damage, modulation of deubiquitinase activity may be of therapeutic value to maintain protein integrity after an ischemic insult.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01-NS109588, R01-NS34179, R01-NS067078)
- Deutsche Forschungsgemeinschaft (KA2279/4-1)
This publication has 86 references indexed in Scilit:
- Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cellsNature Communications, 2013
- On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in ProteasesJournal of the American Chemical Society, 2013
- Deubiquitinases as a Signaling Target of Oxidative StressCell Reports, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Oxidative Stress-Mediated Regulation of Proteasome ComplexesMolecular & Cellular Proteomics, 2011
- Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injuryNeurobiology of Disease, 2011
- Physiologically relevant and portable tandem ubiquitin-binding domain stabilizes polyubiquitylated proteinsProceedings of the National Academy of Sciences of the United States of America, 2010
- A protein microarray-based analysis of S -nitrosylationProceedings of the National Academy of Sciences of the United States of America, 2009
- Modulation of p53 Degradation via MDM2-Mediated Ubiquitylation and the Ubiquitin–Proteasome System during Reperfusion after Stroke: Role of Oxidative StressJournal of Cerebral Blood Flow & Metabolism, 2005
- Oxidative Stress-Associated Impairment of Proteasome Activity during Ischemia–Reperfusion InjuryJournal of Cerebral Blood Flow & Metabolism, 2000